Search

Massive data collection accelerated by the digitisation of healthcare, as well as artificial intelligence, is becoming an essential pillar for prevention.

Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the need to promote effective mechanisms for support, funding, and collaboration to

Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases.

Patients treated with VCN-01 (zabilugene almadenorepvec) plus gemcitabine/nab-paclitaxel standard-of-care (SoC) chemotherapy had increased overall survival, progression free survival, and duration of

Las biotecnológicas Nuage Therapeutics, Ona Therapeutics y SpliceBio, con sede en el Parque Científico de Barcelona, han sido destacadas en un reciente artículo de la revista 'Nature' como referentes

The company increased its normalized EBITDA by 47%, reaching €13.82 million.

Meet our new member MedBioinformatics. We sponke with Ferran Sanz, Founding Partner, Member of the Board of Directors, and Scientific Advisor

Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux Equity Partners

Together, these studies reinforce the concept that advanced peptide-based brain shuttle technologies—central to the Gate2Brain platform—are dynamic and adaptable tools for overcoming the challenges of

Under the motto “Global crossroads, local vibes”, the event aims to connect local talent with European and American ecosystems.